Chimerigen

GFRAL (human):Fc (human) (rec.)

CHF 520.00
In stock
CHI-HF-210GFRAL-C100100 µgCHF 520.00
More Information
Product Details
Synonyms GDNF Family Receptor α-like; Gral; Glial Cellline-derived Neurotrophic Factor Receptor α-like; GFR α-like; C6orf144
Product Type Protein
Properties
Source/Host HEK 293 cells
Sequence

The extracellular domain of human GFRAL (aa 19-351) is fused to the N-terminus of the Fc region of human IgG1.

Crossreactivity Human
Biological Activity

Measured by its binding ability in a functional ELISA.

MW ~50-100kDa
Purity ≥98% (SDS-PAGE)
Endotoxin Content <1EU/mg purified protein (LAL test; Lonza).
Reconstitution Reconstitute at 100μg/ml in sterile PBS.
Formulation Lyophilized from 0.2μm-filtered solution in PBS.
Protein Negative Control

Fc (human) IgG1 Control (rec.)

Other Product Data

NCBI reference NP_997293.2: GFRAL (human)

Declaration Manufactured by Chimerigen.
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Centrifuge lyophilized vial before opening and reconstitution.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Working aliquots are stable for up to 3 months when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

GFRAL (GDNF receptor α-like) is a distant member of the GDNFR family of proteins. Human GFR α-like contains a 333aa extracellular domain, a 20aa transmembrane domain and a 23aa cytoplasmic domain. Over the extracellular domain, human GFRAL shares 72% and 71% identity with mouse and rat GFRAL, respectively. It is expressed on both fetal and adult hindbrain neurons of the CNS and functions as an anti-apoptotic molecule during neuronal stress. GFRAL is a functional receptor for GDF15, facilitating weight-loss functions of the protein through c-Ret downstream signaling. GFRAL and GDF15 signaling is implicated in diet-based obesity and insulin resistance.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.